Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Enlighten Capital, based in the United States, specializes in early-stage investments in healthcare technology. The firm targets pre-seed and seed companies, aiming to enhance medical care and patient outcomes. Their investment strategy is centered on scalable ventures that address significant healthcare challenges.
This firm invests in early-stage digital health technologies that tackle major healthcare issues. Enlighten Capital prioritizes clinical evidence that demonstrates the efficacy and potential impact of these technologies on patient outcomes, ensuring a strong foundation for their investments.
Enlighten Capital's portfolio features innovative healthcare solutions, including wearable technology for real-time monitoring of military personnel, AI platforms for secure patient interactions, and treatments for Long Covid. They also support culturally-responsive mental health care services and HIPAA-compliant AI utilizing OpenAI GPT models.
Submit your pitch through their website contact form for consideration.
Enlighten Capital typically participates in early-stage funding rounds, often leading investments in pre-seed and seed stages.
The firm is open to follow-on investments, particularly in companies that demonstrate significant progress and clinical validation.
Details about the specific size of Enlighten Capital's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.